LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,511
تعداد دریافت فایل اصل مقاله11,291,306
Jaafari, Zahra, Sadidi, Nasrin, Abdolahinia, Zahra, Shahesmaeili, Armita. (1400). Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis. سامانه مدیریت نشریات علمی, 47(1), 15-24. doi: 10.30476/ijms.2020.85941.1557
Zahra Jaafari; Nasrin Sadidi; Zahra Abdolahinia; Armita Shahesmaeili. "Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis". سامانه مدیریت نشریات علمی, 47, 1, 1400, 15-24. doi: 10.30476/ijms.2020.85941.1557
Jaafari, Zahra, Sadidi, Nasrin, Abdolahinia, Zahra, Shahesmaeili, Armita. (1400). 'Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis', سامانه مدیریت نشریات علمی, 47(1), pp. 15-24. doi: 10.30476/ijms.2020.85941.1557
Jaafari, Zahra, Sadidi, Nasrin, Abdolahinia, Zahra, Shahesmaeili, Armita. Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis. سامانه مدیریت نشریات علمی, 1400; 47(1): 15-24. doi: 10.30476/ijms.2020.85941.1557

Prevalence of Depression among Iranian Patients with Beta-Thalassemia Major: A Systematic Review and Meta-analysis

Iranian Journal of Medical Sciences
مقاله 3، دوره 47، شماره 1، فروردین 2022، صفحه 15-24    اصل مقاله (1.72 M)
نوع مقاله: Review Article
شناسه دیجیتال (DOI): 10.30476/ijms.2020.85941.1557
نویسندگان
Zahra Jaafari1؛ Nasrin Sadidi1؛ Zahra Abdolahinia1؛ Armita Shahesmaeili* 2
1Student Research Committee, Kerman University of Medical Sciences, Kerman, Iran
2HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
چکیده
Background: Patients with beta-thalassemia (BT) are susceptible to psychological disorders such as depression. The present study was conducted to estimate the pooled prevalence of depression among patients with BT in Iran.
Methods: Domestic and international databases were searched for relevant articles published from 1991 until June 2019. We searched international databases such as Scopus, ISI, and Embase; Iranian databases such as SID, Magiran, and IranDoc; and Google Scholar and PubMed search engines. The MeSH keywords used were “depression”, “mental health”, “depressive disorder”, “thalassemia”, “beta-thalassemia major”, “prevalence”, “epidemiology”, and “Iran”. Relevant cross-sectional or cohort studies were included in the analysis. Cochran’s Q test and the I2 index were used to assess heterogeneity. The pooled prevalence and its 95% confidence interval (CI) were calculated using “metaprop” commands in Stata 14. In cases, where the I2 statistic was greater than 50%, the random-effects model was used.
Results: Eighteen eligible studies were included. The pooled prevalence of depression was 42% (95% CI: 33% to 52%), whereas the pooled prevalence of mild, moderate, severe, and extremely severe depression was 16% (95% CI: 11% to 22%), 13% (95% CI: 9% to 18%), 13% (95% CI: 9% to 17%), and 3% (95% CI: 0% to 8%), respectively. The pooled prevalence of depression in moderate- and high-quality studies was 45% (95% CI: 29% to 61%), and 39% (95% CI: 27% to 51%), respectively.
Conclusion: The high prevalence of depression highlights the urgent need for the establishment of interventions for the prevention, early detection, and treatment of depression among Iranian patients with BT.
کلیدواژه‌ها
Depression؛ Thalassemia؛ Prevalence؛ Meta-analysis؛ Iran
سایر فایل های مرتبط با مقاله
مراجع
  1. Aydinok Y. Thalassemia. Hematology. 2012;17 Suppl 1:S28-31. doi: 10.1179/102453312X13336169155295. PubMed PMID: 22507773.
  2. Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11. doi: 10.1186/1750-1172-5-11. PubMed PMID: 20492708; PubMed Central PMCID: PMCPMC2893117.
  3. Organization WH. Thalassaemia patients have renewed hope through support provided by the Emergency Health and Nutrition Project. Geneva: World Health Organization. 2019.
  4. Rezaee AR, Banoei MM, Khalili E, Houshmand M. Beta-Thalassemia in Iran: new insight into the role of genetic admixture and migration. ScientificWorldJournal. 2012;2012:635183. doi: 10.1100/2012/635183. PubMed PMID: 23319887; PubMed Central PMCID: PMCPMC3539370.
  5. Jain M, Bagul AS, Porwal A. Psychosocial problems in thalassemic adolescents and young adults. Chronicles of young scientists. 2013;4:21-3. doi: 10.4103/2229-5186.108800.
  6. Ghanizadeh A, Khajavian S, Ashkani H. Prevalence of psychiatric disorders, depression, and suicidal behavior in child and adolescent with thalassemia major. J Pediatr Hematol Oncol. 2006;28:781-4. doi: 10.1097/01.mph.0000243665.79303.9e. PubMed PMID: 17164645.
  7. Mirzaei K. The relationship between social support and depression in patients with thalassemia major in Bushehr, Iran. Nursing of the Vulnerables. 2015;2:1-14.
  8. Organization WH. Depression and other common mental disorders: global health estimates. Geneva: World Health Organization, 2017.
  9. Az-zahra WF, Mardhiyah A, Nurhidayah I. The Depression Categories of Adolescent with Beta-Thalassemia Major. Journal of Nursing Care. 2019;2. doi: 10.24198/jnc.v2i1.20162.
  10. Khoury B, Musallam KM, Abi-Habib R, Bazzi L, Ward ZA, Succar J, et al. Prevalence of depression and anxiety in adult patients with beta-thalassemia major and intermedia. Int J Psychiatry Med. 2012;44:291-303. doi: 10.2190/PM.44.4.a. PubMed PMID: 23885513.
  11. Lyrakos G, Drossou-Servou M, Vini D, Aslani H, Spinaris V. 1467–Symptoms of depression, anxiety and stress in patients with thalassemia in a greek transfusion center. European Psychiatry. 2013;28:1. doi: 10.1016/S0924-9338(13)76495-2.
  12. Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, et al. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010;85:802-5. doi: 10.1002/ajh.21826. PubMed PMID: 20806230; PubMed Central PMCID: PMCPMC4251654.
  13. Yahia S, El-Hadidy MA, El-Gilany AH, Anwar R, Darwish A, Mansour AK. Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study. Int J Hematol. 2013;97:604-9. doi: 10.1007/s12185-013-1322-z. PubMed PMID: 23595950.
  14. Ramazani T, Safarizadeh M, Alimirzaei R, Rahbarifar S, Fatemi M. Relationship between quality of life and psychological disorders of patients with thalassemia. Scientific Journal of Iran Blood Transfus Organ. 2015;11:362-72.
  15. Khamoushi F, Ahmadi SM, Karami-Matin B, Ahmadi-Jouybari T, Mirzaei-Alavijeh M, Ataee M, et al. Prevalence and socio-demographic characteristics related to stress, anxiety, and depression among patients with major thalassemia in the Kermanshah County. J Biol Todey’s World. 2015;4:79-84. doi: 10.15412/J.JBTW.01040304.
  16. Naderi M, Hormozi MR, Ashrafi M, Emamdadi A. Evaluation of Mental Health and Related Factors among Patients with Beta-thalassemia Major in South East of Iran. Iran J Psychiatry. 2012;7:47-51. PubMed PMID: 23056118; PubMed Central PMCID: PMCPMC3395967.
  17. Adib-Hajbaghery M, Ahmadi M, S P. Health Related Quality of Life, Depression, Anxiety and Stress in Patients with Beta-Thalassemia Major. Iran J Ped Hematol Oncol. 2015;5:193-205. PubMed PMID: 26985352; PubMed Central PMCID: PMCPMC4779154.
  18. Poormansouri S, Ahmadi M, Shariati A, Keikhaei B. Quality of life, depression, anxiety and stress in over-18-year-old patients with beta-Thalassemia major. Scientific Journal of Iran Blood Transfus Organ. 2016;13:72-82.
  19. Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1. PubMed PMID: 25554246; PubMed Central PMCID: PMCPMC4320440.
  20. Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. c2011. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
  21. Garcia-Batista ZE, Guerra-Pena K, Cano-Vindel A, Herrera-Martinez SX, Medrano LA. Validity and reliability of the Beck Depression Inventory (BDI-II) in general and hospital population of Dominican Republic. PLoS One. 2018;13:e0199750. doi: 10.1371/journal.pone.0199750. PubMed PMID: 29958268; PubMed Central PMCID: PMCPMC6025862.
  22. Loosman WL, Siegert CE, Korzec A, Honig A. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. Br J Clin Psychol. 2010;49:507-16. doi: 10.1348/014466509X477827. PubMed PMID: 20021730
  23. Sterling M. General Health Questionnaire - 28 (GHQ-28). J Physiother. 2011;57:259. doi: 10.1016/S1836-9553(11)70060-1. PubMed PMID: 22093128.
  24. Basha E, Kaya M. Depression, Anxiety and Stress Scale (DASS): The Study of Validity and Reliability. Universal Journal of Educational Research. 2016;4:2701-5. doi: 10.13189/ujer.2016.041202.
  25. Allgaier AK, Fruhe B, Pietsch K, Saravo B, Baethmann M, Schulte-Korne G. Is the Children’s Depression Inventory Short version a valid screening tool in pediatric care? A comparison to its full-length version. J Psychosom Res. 2012;73:369-74. doi: 10.1016/j.jpsychores.2012.08.016. PubMed PMID: 23062811.
  26. Rotundo N, Hensley VR. The Children’s Depression Scale. A study of its validity. J Child Psychol Psychiatry. 1985;26:917-27. doi: 10.1111/j.1469-7610.1985.tb00606.x. PubMed PMID: 4066816.
  27. Lauth B, Arnkelsson GB, Magnusson P, Skarpheethinsson GA, Ferrari P, Petursson H. Validity of K-SADS-PL (Schedule for Affective Disorders and Schizophrenia for School-Age Children--Present and Lifetime Version) depression diagnoses in an adolescent clinical population. Nord J Psychiatry. 2010;64:409-20. doi: 10.3109/08039481003777484. PubMed PMID: 20438289.
  28. Shafiee A, Nazari S, Jorjani S, Bahraminia E, Sadeghi-Koupaei M. Prevalence of depression in patients with beta-thalassemia as assessed by the Beck’s Depression Inventory. Hemoglobin. 2014;38:289-91. doi: 10.3109/03630269.2014.929008. PubMed PMID: 24986132.
  29. Salehi M, Mirbehbahani N, Jahazi A, Amlashi YA. General health of beta-thalassemia major patients in Gorgan, Iran. Journal of Gorgan University of Medical Sciences. 2014;16:120-5.
  30. Maheri A, Sadeghi R, Shojaeizadeh D, Tol A, Yaseri M, Rohban A. Depression, Anxiety, and Perceived Social Support among Adults with Beta-Thalassemia Major: Cross-Sectional Study. Korean J Fam Med. 2018;39:101-7. doi: 10.4082/kjfm.2018.39.2.101. PubMed PMID: 29629042; PubMed Central PMCID: PMCPMC5876044.
  31. Sarafraz M, Mohammadzadeh A, Nikkhah Khaje Ataei B. Prevalence of Depression Among Patients With Thalassemia in Southern of Iran. International Electronic Journal of Medicine. 2018;7:38-42. doi: 10. 31661/iejm581.
  32. Izadyar M, Sedighipourand L, Jafarieh H, Fatahi F. Evaluation Of compliance To Iron Chelation Therapy With Defe-Roxamine In Patients With Major Thalassemia In Iran In 2004. Tehran University Medical Journal TUMS Publications. 2006;64:180-8.
  33. Moafi A, Mobaraki G, Taheri SS, Heidarzadeh A, Shahabi I, Majidi F. Zinc in thalassemic patients and its relation with depression. Biol Trace Elem Res. 2008;123:8-13. doi: 10.1007/s12011-008-8116-9. PubMed PMID: 18338112.
  34. Haji seyedJavadi AR, Shafikhani AA. Evaluation of depression and anxiety in patients with thalassemia: a comparative study. J Qazvin Univ Med Sci. 2017;21:13-21. Persian.
  35. Ghaffari Saravi V, Zarghmi M, Ebrahimi E. The prevalence of depression in Thalassemic patients in the city of Sari. Iranian Journal of Psychiatry and Clinical Psychology. 2004;9:33-40.
  36. Aziznejad P, Hosseni J, Shakerei J. Comparison between the frequency of depression among adolescents whit and without thalassemia in Babol, 2007. Scientific Journal of Nursing, Midwifery and Paramedical Faculty. 2008;2:31-8. Persian.
  37. Hashemi AS, Banaei-Boroujeni S, Kokab N. Prevalence of major depressive and anxiety disorders in hemophilic and major beta thalassemic patients. Iranian Journal of Pediatric Hematology and Oncology. 2012;2:11-6.
  38. Marvasti VE, Dastoori P, Karimi M. Is beta-thalassemia trait a risk factor for developing depression in young adults? Ann Hematol. 2006;85:873-4. doi: 10.1007/s00277-006-0154-9. PubMed PMID: 16845515.
  39. Yengil E, Acipayam C, Kokacya MH, Kurhan F, Oktay G, Ozer C. Anxiety, depression and quality of life in patients with beta thalassemia major and their caregivers. Int J Clin Exp Med. 2014;7:2165-72. PubMed PMID: 25232402; PubMed Central PMCID: PMCPMC4161562.
  40. Braam AW, Schrier AC, Tuinebreijer WC, Beekman AT, Dekker JJ, de Wit MA. Religious coping and depression in multicultural Amsterdam: a comparison between native Dutch citizens and Turkish, Moroccan and Surinamese/Antillean migrants. J Affect Disord. 2010;125:269-78. doi: 10.1016/j.jad.2010.02.116. PubMed PMID: 20334926.
  41. Juhasz G, Eszlari N, Pap D, Gonda X. Cultural differences in the development and characteristics of depression. Neuropsychopharmacol Hung. 2012;14:259-65. PubMed PMID: 23269213.
  42. Griffiths KM, Crisp DA, Jorm AF, Christensen H. Does stigma predict a belief in dealing with depression alone? J Affect Disord. 2011;132:413-7. doi: 10.1016/j.jad.2011.03.012. PubMed PMID: 21440305.
  43. Yang F, Yang BX, Stone TE, Wang XQ, Zhou Y, Zhang J, et al. Stigma towards depression in a community-based sample in China. Compr Psychiatry. 2020;97:152152. doi: 10.1016/j.comppsych.2019.152152. PubMed PMID: 31838297.
  44. Mohamadi M, Mohaqeqi Kamal SH, Vameghi M, Rafiey H, Setareh Forouzan A, Sajjadi H. A meta-analysis of studies related prevalence of depression in Iran. Journal of Research and Health. 2017;7:581-93. doi: 10.18869/acadpub.jrh.7.1.581.
  45. Borras L, Constant EL. Depression and beta-thalassemia: a genetic link? Acta Neuropsychiatrica. 2007;19:134. doi: 10.1111/j.1601-5215.2006.00180.x.
  46. Koutelekos J, Haliasos N. Depression and Thalassemia in children, adolescents and adults. Health Science Journal. 2013;7:239.
  47. Munoz RF, Beardslee WR, Leykin Y. Major depression can be prevented. Am Psychol. 2012;67:285-95. doi: 10.1037/a0027666. PubMed PMID: 22583342; PubMed Central PMCID: PMCPMC4533896.
آمار
تعداد مشاهده مقاله: 7,651
تعداد دریافت فایل اصل مقاله: 4,295


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب